1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Medicine
        1.2.3 Surgery
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2017-2028)
    2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Region
        2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2017-2022)
        2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028)
    2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
        2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
        2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
        2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
        2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
        3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2017-2022)
        3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2017-2022)
    3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
    3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
        3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2021
    3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
    3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
    3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
    4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2017-2022)
    4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
    5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2017-2022)
    5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
    6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
        6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
        6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
        6.2.3 North America Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
    6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
        6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
        6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
        6.3.3 North America Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
    6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
        6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
        6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
    7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
        7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
        7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
        7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
    7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
        7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
        7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
        7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
    7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
        7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
        7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
    8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type
        8.2.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application
        8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region
        8.4.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
    9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
        9.2.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
        9.2.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
        9.2.3 Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
    9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
        9.3.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
        9.3.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
        9.3.3 Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
    9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
        9.4.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
        9.4.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
    10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type
        10.2.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application
        10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country
        10.4.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
        11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Astellas Pharma
        11.2.1 Astellas Pharma Company Details
        11.2.2 Astellas Pharma Business Overview
        11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
        11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.2.5 Astellas Pharma Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
        11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Novartis International
        11.4.1 Novartis International Company Details
        11.4.2 Novartis International Business Overview
        11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
        11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.4.5 Novartis International Recent Developments
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
        11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.5.5 Merck Recent Developments
    11.6 Veru
        11.6.1 Veru Company Details
        11.6.2 Veru Business Overview
        11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
        11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.6.5 Veru Recent Developments
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
        11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.7.5 Sanofi Recent Developments
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Details
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
        11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.8.5 GlaxoSmithKline Recent Developments
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
        11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.9.5 Bayer Recent Developments
    11.10 Orion
        11.10.1 Orion Company Details
        11.10.2 Orion Business Overview
        11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
        11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.10.5 Orion Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Company Details
        11.11.2 AstraZeneca Business Overview
        11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
        11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
        11.11.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Medicine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2017-2022)
    Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2023-2028)
    Table 11. Androgen Deprivation Therapy (ADT) Market Trends
    Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
    Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
    Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
    Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2017-2022)
    Table 17. Global Top Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
    Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
    Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2017-2022)
    Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2023-2028)
    Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2017-2022)
    Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application (2023-2028)
    Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Androgen Deprivation Therapy (ADT) Product
    Table 65. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Astellas Pharma Company Details
    Table 68. Astellas Pharma Business Overview
    Table 69. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
    Table 70. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 71. Astellas Pharma Recent Developments
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
    Table 75. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 76. Johnson & Johnson Recent Developments
    Table 77. Novartis International Company Details
    Table 78. Novartis International Business Overview
    Table 79. Novartis International Androgen Deprivation Therapy (ADT) Product
    Table 80. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 81. Novartis International Recent Developments
    Table 82. Merck Company Details
    Table 83. Merck Business Overview
    Table 84. Merck Androgen Deprivation Therapy (ADT) Product
    Table 85. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 86. Merck Recent Developments
    Table 87. Veru Company Details
    Table 88. Veru Business Overview
    Table 89. Veru Androgen Deprivation Therapy (ADT) Product
    Table 90. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 91. Veru Recent Developments
    Table 92. Sanofi Company Details
    Table 93. Sanofi Business Overview
    Table 94. Sanofi Androgen Deprivation Therapy (ADT) Product
    Table 95. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 96. Sanofi Recent Developments
    Table 97. GlaxoSmithKline Company Details
    Table 98. GlaxoSmithKline Business Overview
    Table 99. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
    Table 100. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 101. GlaxoSmithKline Recent Developments
    Table 102. Bayer Company Details
    Table 103. Bayer Business Overview
    Table 104. Bayer Androgen Deprivation Therapy (ADT) Product
    Table 105. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 106. Bayer Recent Developments
    Table 107. Orion Company Details
    Table 108. Orion Business Overview
    Table 109. Orion Androgen Deprivation Therapy (ADT) Product
    Table 110. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 111. Orion Recent Developments
    Table 112. AstraZeneca Company Details
    Table 113. AstraZeneca Business Overview
    Table 114. AstraZeneca Androgen Deprivation Therapy (ADT) Product
    Table 115. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
    Table 116. AstraZeneca Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2021 VS 2028
    Figure 2. Medicine Features
    Figure 3. Surgery Features
    Figure 4. Other Features
    Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Other Case Studies
    Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered
    Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2021 VS 2028
    Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2021
    Figure 14. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2021
    Figure 16. North America Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
    Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
    Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
    Figure 20. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
    Figure 26. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Androgen Deprivation Therapy (ADT) Market Size Share by Region (2017-2028)
    Figure 36. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
    Figure 46. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size Share by Country (2017-2028)
    Figure 52. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 56. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 58. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 60. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 61. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 62. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 63. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 64. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 65. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed